Description
A potent, competitive inhibitor of HMG-CoA reductase (Ki = 0.12 nM); 8 mg/kg/day for 18 days reduces plasma cholesterol levels by 33% in dogs; suppresses TNF-induced NF-κB activation (IC50 ~ 13 µM),
Formal name: (βR,δR,1S,2S,6R,8S,8aR)-8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic acid, monosodium salt
Synonyms:
Molecular weight: 458.6
CAS: 101314-97-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Product Type|Biochemicals|Small Molecule Inhibitors|TNF-α/NF-κB Signaling||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|NF-κB Signaling||Research Area|Cancer|Transcription Factors|NF-κB||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism